Metformin for Weight Reduction in Adolescent Girls

Efficacy of Metformin for Weight Reduction

Metformin produces only modest weight loss in obese adolescents, with randomized controlled trials showing placebo-subtracted BMI reductions of approximately 1.1 kg/m² (about 3% reduction in BMI) over treatment periods of 6-12 months 1, 3, 4
A meta-analysis of 5 studies with treatment periods ≥6 months reported a placebo-subtracted reduction in BMI of 1.42 kg/m² 3
Studies specifically focused on adolescents with severe obesity have not been reported 3

Metformin has a strong safety track record, but gastrointestinal side effects (mainly nausea and vomiting) are common, though usually mild in severity 3
Metformin is contraindicated in patients with impaired renal function, hepatic disease, hypoxemic conditions, severe infections, or alcohol abuse 5

The American Heart Association notes that metformin should be considered primarily for youth at high risk for developing type 2 diabetes (e.g., those with impaired glucose tolerance, elevated hemoglobin A1c, or family history of diabetes) 3
The Expert Panel on Integrated Guidelines for Cardiovascular Health suggests that in adolescents with severe obesity and insulin resistance, metformin may be added to a comprehensive lifestyle weight-loss program to improve fasting insulin levels and reduce weight and BMI (Grade B recommendation) 7
For adolescents with obesity but without specific comorbidities, orlistat (not metformin) is mentioned as a potential medication option when lifestyle interventions fail 7

First-line approach: Comprehensive lifestyle modification including dietary changes, physical activity, and behavioral therapy 1, 7
For adolescents with BMI ≥95th percentile WITH insulin resistance or prediabetes: Consider adding metformin to lifestyle interventions 3, 7
When considering metformin, dosing should start with extended-release formulation (2000 mg once daily) or shorter-acting formulation (1000 mg twice daily or 1000 mg morning/500 mg evening) 3
Evaluate efficacy after 3-6 months; discontinue if BMI reduction is <4% 6

Metformin may normalize ovulatory abnormalities in girls with Polycystic Ovary Syndrome (PCOS), potentially increasing risk of unplanned pregnancy 5
Preconception and pregnancy counseling should be part of the treatment regimen for adolescent girls 5
Metformin should not be used during pregnancy 5